Frèdèrique Menzaghi founded CARA Therapeutics, Inc. and Sibia Neurosciences, Inc.

She holds the position of Chief Scientific Officer, Senior VP-R&D at CARA Therapeutics, Inc.

In the past Dr. Menzaghi held the position of Principal at Eli Lilly & Co., Vice President-Pharmacology & Business Development at Psychogenics, Inc., Director-Preclinical Research Laboratory at Sibia Neurosciences, Inc. and Director-In Vivo Pharmacology at Arena Pharmaceuticals, Inc.

Dr. Menzaghi received a graduate degree from Ecole des Mines de Nancy and a doctorate from the University of Strasbourg.